Cornerstone BioPharma Further Expands Nationwide Sales Force; Specialty Pharmaceutical Company Adds 25 Sales Reps Across the Country.CARY, N.C. -- Cornerstone cornerstone Ceremonial building block, dated or otherwise inscribed, usually placed in an outer wall of a building to commemorate its dedication. Often the stone is hollowed out to contain newspapers, photographs, or other documents reflecting current customs, with a view to BioPharma, Inc., the Triangle-based specialty pharmaceutical company currently focused on the development and commercialization of niche prescription medications in the pain, anti-infective an·ti-in·fec·tive adj. Capable of preventing or counteracting infection. n. An anti-infective agent or drug. anti-infective 1. counteracting infection. 2. a substance that counteracts infection. , and respiratory markets, has continued to successfully execute its expansion strategy and recruiting campaign for an additional 25 sales representatives nationwide. This announcement comes just months after Cornerstone completed its first round of their sales force expansion, and announced the hiring of 50 new representatives in April. The recruiting campaign has been led by Kevin McAdams, Vice President of Sales. "I continue to thank our sales leadership team for a job well done. The new additions to the Cornerstone sales force will undoubtedly add to the growing success of our company in the niche specialty biopharma sector." In June, Cornerstone BioPharma announced it received FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval for prescription BALACET 325(TM)for the treatment of mild to moderate pain in patients 18 years of age and older. The company has several more product launches planned for 2005 and this sales force will play a critical role in not only the sales of the products, but the education of health care providers, which will ultimately drive the success of these brands. The company is developing a commercially strong product portfolio and development pipeline that will fuel expansion plans. ABOUT CORNERSTONE BIOPHARMA, INC. Cornerstone BioPharma, Inc., located next to North Carolina's Research Triangle Park Research Triangle Park, research, business, medical, and educational complex situated in central North Carolina. It has an area of 6,900 acres (2,795 hectares) and is 8 × 2 mi (13 × 3 km) in size. Named for the triangle formed by Duke Univ. , is an emerging specialty pharmaceutical company that is currently focused on the development and commercialization of niche prescription medications in the pain, anti-infective, and respiratory markets. The privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. owns the rights to a pain product line, three respiratory product lines, and co-promotes the Suprax(R) antibiotic antibiotic, any of a variety of substances, usually obtained from microorganisms, that inhibit the growth of or destroy certain other microorganisms. Types of Antibiotics . Cornerstone is actively engaged in the licensing of additional prescription products in niche markets A niche market also known as a target market is a focused, targetable portion (subset) of a market sector. By definition, then, a business that focuses on a niche market is addressing a need for a product or service that is not being addressed by mainstream providers. through acquisitions and strategic partnerships. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion